Abstract
Background
Sentinel lymph node biopsy (SLNB) is the standard method for axillary staging of early breast cancer. Recent studies have focused on questioning the initial contraindication to the technique. There has been insufficient data to recommend SLNB in patients with previous aesthetic breast surgery.
Materials and Methods
Between April 2001 and June 2007, 70 patients with previous breast aesthetic surgery underwent SLNB. Fifty had a previous breast augmentation and 20 had breast reduction mammoplasty. All patients underwent lymphoscintigraphy with 99Tc according to our standard technique and sentinel node was identified in all cases.
Results
Mean age at cosmetic surgery was 38 years. Mean number of years from aesthetic surgery to the development of the tumour was 10 years. Forty-nine patients underwent conservative breast surgery and 21 patients underwent mastectomy. The sentinel node identification rate was 100%. SLN was positive in 23 patients (32%); there were 18 cases with macrometastasis and 7 cases with micrometastasis. After median follow-up of 19 months, no axillary recurrences have been observed. We observed two ipsilateral local recurrences, one contralateral tumour and one patient developed lung metastasis.
Conclusions
Past history of breast augmentation or reduction is not a contraindication to SLNB technique.
Similar content being viewed by others
References
Krag D, Weaver D, Ashikana T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339:941–6.
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983–90.
Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy can avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes. Lancet. 1997;349:1864–7.
Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20. Epub 2005 Sep 12.
Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifiro G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89(2):159–63.
Heuts EM, van der Ent FW, Kengen RA, van der Pol HA, Hulsewe KW, Hoofwijk AG. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol. 2006;32(3):278–81. Epub 2005 Oct 24.
Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21–7.
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9(3):272–7.
Cody HS III. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions. J Surg Oncol. 2007;95(6):440–2.
Intra M, Rotmensz N, Mattar D, Gentilini OD, Vento A, Veronesi P, et al. Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer. 2007;43(18):2664–8. Epub 2007 Oct 10.
Paganelli G, Galimberti V, Trifirò G, Travaini L, De Cicco C, Mazzarol G, et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med. 2002;46:138–44.
Ries LAG, Eisner MP, Kosary CL. SEER cancer statistics review 1975–2002. Bethesda, MD: National Cancer Institute; 2005.
Taback B, Nguyen P, Hansen sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol. 2006;13(8):1099–104. Epub 2006 Jun 21.
Intra M, Trifirò G, Galimberti V. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg. 2007;94(10):1216–9.
Munhoz AM, Aldrighi C, Buschpiegel C, Ono C, Montag E, Fells K, et al. The feasibility of sentinel lymph node detection in patients with previous transaxillary implant breast augmentation: preliminary results. Aesth Plast Surg. 2005;29:163–8.
Prado A, Andrades P, Leniz P. Implications of Transaxillary Breast Augmentation: Lifetime Probability of Breast Cancer Development and Sentinel Node Mapping Interference. Aesth Plast Surg. 2007;31:317–9.
Mottura AA, Del Castillo R. Transaxillary breast augmentation: two breast cancer patients with successful sentinel lymph node diagnosis. Aesth Plast Surg. 2007;31:544–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodriguez Fernandez, J., Martella, S., Trifirò, G. et al. Sentinel Node Biopsy in Patients with Previous Breast Aesthetic Surgery. Ann Surg Oncol 16, 989–992 (2009). https://doi.org/10.1245/s10434-009-0349-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-009-0349-0